ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.667,83
0,85%
S&P 500
6.032,38
0,56%
US Dollar vs BRL
5,97435
0,00%
Bitcoin
96.452,17
-1,06%
Brent Oil
71,98
-0,08%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Astellas Pharma Inc (PK) (ALPMY)

  7. Astellas Pharma Inc (PK) (ALPMY) Notícias

ALPMY

Astellas Pharma (PK) (ALPMY)

Astellas Pharma Inc (PK)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:ALPMY
DataHoraFonteTítuloCódigoCompanhia
15/12/202319:53Dow Jones NewsMerck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
30/11/202320:04Dow Jones NewsAstellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License Application Gets FDA Priority ReviewUSOTC:ALPMYAstellas Pharma Inc (PK)
22/09/202308:02Dow Jones NewsMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits EndpointsUSOTC:ALPMYAstellas Pharma Inc (PK)
07/08/202311:41Dow Jones NewsPoseida Therapeutics Shares Leap on Astellas InvestmentsUSOTC:ALPMYAstellas Pharma Inc (PK)
07/08/202310:58Dow Jones NewsPoseida Therapeutics in $50 Million Investment Deal With AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
30/04/202321:57Dow Jones NewsAstellas Pharma to Buy Iveric Bio for About $5.9 BillionUSOTC:ALPMYAstellas Pharma Inc (PK)
09/01/202312:49Dow Jones NewsSelecta Biosciences Shares Rise 11% After Licensing Deal With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
25/10/202207:26Dow Jones NewsTaysha Gene Therapies Shares Soar Premarket on Astellas InvestmentUSOTC:ALPMYAstellas Pharma Inc (PK)
28/06/202211:28Dow Jones NewsSutro Biopharma Shares Rise 24% After Collaboration With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
27/06/202221:37Dow Jones NewsSutro Biopharma Shares Soar 67% on Cancer Treatment Collaboration with AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
13/04/202213:31Dow Jones NewsEuropean Commission Approves Drug for Urothelial CancerUSOTC:ALPMYAstellas Pharma Inc (PK)
17/12/202109:37Dow Jones NewsAstellas Pharma, Seagen Get CHMP Positive Opinion for PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
11/08/202108:54Dow Jones NewsFDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney DiseaseUSOTC:ALPMYAstellas Pharma Inc (PK)
21/12/201719:17Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:ALPMYAstellas Pharma Inc (PK)
29/09/201714:03Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)USOTC:ALPMYAstellas Pharma Inc (PK)
22/08/201609:50Dow Jones NewsPfizer Adds Key Cancer Drug in $14 Billion Biotech DealUSOTC:ALPMYAstellas Pharma Inc (PK)
09/07/201604:02Dow Jones NewsCorrections & Amplifications -- WSJUSOTC:ALPMYAstellas Pharma Inc (PK)
07/07/201602:20Dow Jones NewsTest Aids Prostate Cancer TreatmentUSOTC:ALPMYAstellas Pharma Inc (PK)
01/06/201619:40Dow Jones NewsSanofi Asks for Record Date for Vote on Medivation's BoardUSOTC:ALPMYAstellas Pharma Inc (PK)
28/04/201619:10Dow Jones NewsDrugmakers Place Big Bets on Cancer MedicinesUSOTC:ALPMYAstellas Pharma Inc (PK)
29/03/201611:50Dow Jones NewsLawmakers Target Medivation Over Drug PricesUSOTC:ALPMYAstellas Pharma Inc (PK)
04/12/201519:03The Motley FoolOcata Therapeutics Almost Doubled in November -- Here's WhyUSOTC:ALPMYAstellas Pharma Inc (PK)
25/11/201512:04The Motley FoolJohnson & Johnson's Latest FDA Approval Could Spell Problems for AmgenUSOTC:ALPMYAstellas Pharma Inc (PK)
23/11/201513:07The Motley Fool3 Value Stocks Near 52-Week Lows Worth BuyingUSOTC:ALPMYAstellas Pharma Inc (PK)
06/11/201515:40The Motley FoolMedivation Inc is Down Today -- But Why?USOTC:ALPMYAstellas Pharma Inc (PK)
02/11/201510:34The Motley Fool3 Stocks to Buy Now in BiotechUSOTC:ALPMYAstellas Pharma Inc (PK)
15/07/201515:33Dow Jones NewsAsian Shares: China Stocks Tumble as Investors Doubt Beijing's HelpUSOTC:ALPMYAstellas Pharma Inc. ADR
22/03/201508:01The Motley FoolBest One-Drug Wonder Stock for 2015USOTC:ALPMYAstellas Pharma Inc (PK)
30/01/201502:30Dow Jones NewsValeant to Buy Prostate-Cancer Drug From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
30/01/201502:10Dow Jones NewsValeant in Deal to Buy Prostate-Cancer Drug Provenge From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
 Apresentando as notícias mais relevantes sobre:USOTC:ALPMY

Seu Histórico Recente

BIT
ETFEU
Amundi Prime Europe Ucit...
BOV
NFLX34R
Netflix
BOV
BTLT39Q
BlackRock Institutional ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 50%* para TRADER BRASIL

1 ano 30%, 2 anos 40% e *3 anos 50%

*Ao longo de 3 anos $ 881.64 apenas $ 440.82